MediPal Holdings Corp - Company Profile

Powered by

All the data and insights you need on MediPal Holdings Corp in one report.

  • Save hours of research time and resources with
    our up-to-date MediPal Holdings Corp Strategy Report

  • Understand MediPal Holdings Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

MediPal Holdings Corp: Overview

MediPal Holdings Corp (MediPal) controls, administers and supports the operating activities of its group companies which are primarily engaged in the wholesale distribution of prescription pharmaceutical products, over-the-counter (OTC) pharmaceuticals, animal health products, cosmetics, daily necessities and food processing raw materials. The company distributes products to hospitals, prescription pharmacies, clinics, drug stores, home centers, convenience stores, supermarkets, animal hospitals, livestock clinics, livestock farms, fisheries, processed food manufactures, and others. Major subsidiaries include Mediceo Corporation, EVERLTH Co Ltd, ATOL Co Ltd, PALTAC Corporation, MP AGRO Co Ltd, Medipal Foods Co Ltd and EVERLTH Audi S Co Ltd. MediPal delivers products through distribution centers spread across Japan. MediPal is headquartered in Chuo-ku, Tokyo, Japan.

Gain a 360-degree view of MediPal Holdings Corp and make more informed decisions for your business Gain a 360-degree view of MediPal Holdings Corp and make more informed decisions for your business Find out more
Headquarters Japan

Address 3-1-1, Kyobashi, Chuo-Ku, Tokyo, 104-0031


Telephone 81 3 35175800

No of Employees 12,795

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 7459 (TYO)

Revenue (2023) $24.8B 2.1% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 31.9% (2023 vs 2022)

Market Cap* $3.4B

Net Profit Margin (2023) XYZ 29.2% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

MediPal Holdings Corp premium industry data and analytics

13+

Clinical Trials

Determine MediPal Holdings Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

10+

Catalyst Calendar

Proactively evaluate MediPal Holdings Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Pipeline Drugs

Identify which of MediPal Holdings Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on MediPal Holdings Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Services
Wholesale Distribution
Cosmetics
Clinical Diagnostics
XYZ
XYZ
XYZ
Understand MediPal Holdings Corp portfolio and identify potential areas for collaboration Understand MediPal Holdings Corp portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 New Products/Services In January, the company introduced the website Rare Disease Insights for Everyone.
2023 Contracts/Agreements In September, MEDICEO CORPORATION and SHINYEI Technology Co. developed a system to find abnormalities in material handling equipment.
2023 Contracts/Agreements In September, the company concluded two agreements on JR-446 using JCR's proprietary J-Brain Cargo technology, for the treatment of Mucopolysaccharidosis Type IIIB.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters MediPal Holdings Corp Cencora Inc Cardinal Health Inc Suzuken Co Ltd Toho Holdings Co Ltd
Headquarters Japan United States of America United States of America Japan Japan
City Chuo-Ku Conshohocken Dublin Nagoya-Shi Setagaya-Ku
State/Province Tokyo Pennsylvania Ohio Aichi Tokyo
No. of Employees 12,795 42,000 48,000 13,429 7,699
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Shuichi Watanabe Chief Executive Officer; Director; President Executive Board 2012 71
Yuji Sakon General Manager of Administration Division; Director Executive Board 2012 69
Seiichi Kasuya Director; Chief Operating Officer Executive Board 2019 60
Koichi Mimura Director Executive Board 2021 66
Nagafuku Yasuhiro Director; Vice President - Pharmaceutical sales Executive Board 2019 69
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into MediPal Holdings Corp key executives to enhance your sales strategy Gain insight into MediPal Holdings Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward